E. Montegriffo

447 total citations
7 papers, 271 citations indexed

About

E. Montegriffo is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, E. Montegriffo has authored 7 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Public Health, Environmental and Occupational Health, 2 papers in Molecular Biology and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in E. Montegriffo's work include Reproductive Health and Contraception (3 papers), Ectopic Pregnancy Diagnosis and Management (2 papers) and Maternal and fetal healthcare (1 paper). E. Montegriffo is often cited by papers focused on Reproductive Health and Contraception (3 papers), Ectopic Pregnancy Diagnosis and Management (2 papers) and Maternal and fetal healthcare (1 paper). E. Montegriffo collaborates with scholars based in United Kingdom, United States and Germany. E. Montegriffo's co-authors include U.P. Strauss, Bonne Biesma, David F. Heigener, Joachim von Pawel, Yan Sun, Armando Santoro, Jaafar Bennouna, Steven Gans, Luis Paz‐Ares and Li Zhang and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Fertility and Sterility.

In The Last Decade

E. Montegriffo

7 papers receiving 262 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Montegriffo United Kingdom 4 148 143 94 45 35 7 271
Karen Daily United States 10 138 0.9× 94 0.7× 50 0.5× 68 1.5× 29 0.8× 47 310
Rebecca Herbertson United Kingdom 8 153 1.0× 78 0.5× 48 0.5× 22 0.5× 42 1.2× 18 295
Kikuo Aizawa Japan 11 117 0.8× 192 1.3× 78 0.8× 26 0.6× 34 1.0× 29 481
Jacopo Giuliani Italy 12 206 1.4× 194 1.4× 39 0.4× 48 1.1× 34 1.0× 76 391
P. Lippe Italy 11 294 2.0× 172 1.2× 154 1.6× 23 0.5× 55 1.6× 20 426
Wei‐Chun Hsu United States 8 175 1.2× 242 1.7× 95 1.0× 97 2.2× 47 1.3× 15 424
Tomoyo Oguri Japan 11 183 1.2× 173 1.2× 63 0.7× 39 0.9× 39 1.1× 28 321
Ciro Guerriero Italy 11 192 1.3× 149 1.0× 123 1.3× 35 0.8× 37 1.1× 21 337
Ming Lin United States 4 300 2.0× 324 2.3× 122 1.3× 62 1.4× 23 0.7× 4 439
Chin-Yu Lin United States 7 133 0.9× 327 2.3× 68 0.7× 25 0.6× 37 1.1× 8 494

Countries citing papers authored by E. Montegriffo

Since Specialization
Citations

This map shows the geographic impact of E. Montegriffo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Montegriffo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Montegriffo more than expected).

Fields of papers citing papers by E. Montegriffo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Montegriffo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Montegriffo. The network helps show where E. Montegriffo may publish in the future.

Co-authorship network of co-authors of E. Montegriffo

This figure shows the co-authorship network connecting the top 25 collaborators of E. Montegriffo. A scholar is included among the top collaborators of E. Montegriffo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Montegriffo. E. Montegriffo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Operschall, Elisabeth, et al.. (2016). Baseline Demographic Profile Of Subjects Of The Phase 3 Respire 2 Trial Of Ciprofloxacin Dry Powder For Inhalation (dpi) In Non-Cystic Fibrosis Bronchiectasis (ncfb). 3 indexed citations
2.
Gemzell‐Danielsson, Kristina, et al.. (2016). A Phase III, single-arm study of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5mg) in postmenarcheal adolescents. Contraception. 93(6). 507–512. 30 indexed citations
3.
Gemzell‐Danielsson, Kristina, Kai J. Bühling, Eeva Lukkari‐Lax, et al.. (2014). A multicenter, open-label, single-arm study exploring the safety of a new 13.5 mg total dose levonorgestrel intrauterine contraceptive system in postmenarcheal adolescents. Fertility and Sterility. 102(3). e12–e13. 2 indexed citations
5.
Paz‐Ares, Luis, Bonne Biesma, David F. Heigener, et al.. (2012). Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Gemcitabine/Cisplatin Alone or With Sorafenib for the First-Line Treatment of Advanced, Nonsquamous Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 30(25). 3084–3092. 198 indexed citations
6.
Eisen, Tim, Richard Marais, Annette Affolter, et al.. (2011). Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies. British Journal of Cancer. 105(3). 353–359. 33 indexed citations
7.
Holman, Rury R., et al.. (1999). Acarbose Maintains Glycaemic Control in Diet Treated Type 2 Diabetes. Clinical Science. 96(s40). 7P–7P. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026